Neogen (Nasdaq: NEOG) reported earnings on March 26. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended Feb. 28 (Q3), Neogen beat slightly on revenues and missed estimates on earnings per share.

Compared to the prior-year quarter, revenue grew. GAAP earnings per share grew significantly.

Margins expanded across the board.

Revenue details
 Neogen booked revenue of $51.1 million. The three analysts polled by S&P Capital IQ expected to see net sales of $50.5 million on the same basis. GAAP reported sales were 14% higher than the prior-year quarter's $44.9 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.27. The two earnings estimates compiled by S&P Capital IQ forecast $0.28 per share. GAAP EPS of $0.27 for Q3 were 23% higher than the prior-year quarter's $0.22 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 53.5%, 250 basis points better than the prior-year quarter. Operating margin was 18.9%, 210 basis points better than the prior-year quarter. Net margin was 13.0%, 130 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $54.5 million. On the bottom line, the average EPS estimate is $0.31.

Next year's average estimate for revenue is $206.3 million. The average EPS estimate is $1.13.

Investor sentiment
 The stock has a three-star rating (out of five) at Motley Fool CAPS, with 245 members out of 254 rating the stock outperform, and nine members rating it underperform. Among 61 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 61 give Neogen a green thumbs-up, and give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Neogen is outperform, with an average price target of $51.00.

Looking for alternatives to Neogen? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.